Advertisement
Gleaning Insights on Embryo Development
By Nina Desai, PhD, HCLD
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
The health risks for both patient and fetus associated with high-order multiple pregnancy have spearheaded a movement to limit the overall number of embryos transferred during in vitro fertilization (IVF) to just one for young patients.
Oocytes extracted during IVF surgery can be inseminated or directly injected with sperm to create embryos. The average young patient generates eight to 15 embryos per IVF cycle.
Embryo selection for transfer is based on critical assessment of morphological parameters during embryonic development. Currently, these morphological assessments are limited to once a day at set times, since repeated removal of embryos from the incubator environment for observation may result in undesired temperature and pH shifts in the embryo culture dish.
Embryo development is a dynamic event. Static observations on embryonic growth can therefore be limiting in their ability to discern differences between embryos at a similar cell stage.
Numerous data suggest that the timing of specific events, such as pronuclear formation, syngamy, early cleavage, compaction and cavitation, indicates an embryo’s developmental potential. The ability to continuously monitor an embryo’s progression toward these benchmarks may therefore aid in selecting the best embryos for uterine transfer.
The EmbryoScope® is an FDA-cleared incubator with a built-in camera that allows continual observation of embryos using time-lapse imaging. This special incubator and the software to simultaneously analyze and contrast developmental benchmarks for up to 72 embryos at a time (six patients with 12 embryos per dish) is a powerful new tool for the IVF laboratory.
Advertisement
This instrument will also contribute to our understanding of early events in preimplantation embryo development and to the identification of new grading criteria that may be more predictive of implantation potential. The EmbryoScope also provides a safe, controlled environment for human embryo cultivation without disturbance.
Dr. Desai, Director of the IVF Laboratory in Cleveland Clinic’s Fertility Center, is a member of the Department of Obstetrics and Gynecology.
Advertisement
Advertisement
Treatment being offered in cases where medical and hormonal management was not successful
Standardizing obstetrics and gynecology education while promoting patient safety
High physician/patient convenience and satisfaction cited
Automated visual evaluation of the cervix
Don’t miss this educational opportunity
The next evolution in MIS is coming sooner than you think
Limit radiation damage to ovaries without removing them
Trainees no longer need to “practice” on patients